Study design and quality of reporting of randomized controlled trials of chronic idiopathic or autoimmune urticaria: review.
<h4>Background</h4>The recommended first-line therapy of chronic urticaria is second-generation antihistamines, but the modalities of treatment remains unclear. Numerous recommendations with heterogeneous conclusions have been published. We wondered whether such heterogeneous conclusions...
Saved in:
Main Authors: | Elodie Le Fourn, Bruno Giraudeau, Olivier Chosidow, Marie-Sylvie Doutre, Gérard Lorette |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/ceb2e86d36954d6fa07d74cdb6c50945 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of initial treatment modality on long-term control of chronic idiopathic urticaria.
by: Sujeong Kim, et al.
Published: (2013) -
Participant informed consent in cluster randomized trials: review.
by: Bruno Giraudeau, et al.
Published: (2012) -
STUDIES ON THE ROLE OF CYTOKINES POLYMORPHISM IN PATHOGENESIS OF CHRONIC URTICARIA
by: N. I. Baranova, et al.
Published: (2015) -
Skin Prick Test with Aeroallergens in Patients with Chronic Urticaria
by: J Ghaffari, et al.
Published: (2012) -
FEATURES OF IMMUNE RESPONSE AND BASOPHIL ACTIVATION IN CHILDREN WITH CHRONIC URTICARIA
by: N. A. Sinelnikova, et al.
Published: (2015)